Hap Trading, LLC Mersana Therapeutics, Inc. Call Options Transaction History

Hap Trading, LLC

4 transactions

Quarter	Operation	Price Per call	calls change	calls Held
Q2 2023 Aug 11, 2023	BUY	$3.08 - $9.55 $924 - $2,865	300 Added 0.08%	390,300 $1.28 Million
Q1 2023 May 12, 2023	BUY	$4.0 - $7.02 $1.56 Million - $2.74 Million	390,000 New	390,000 $59,000
Q3 2020 Nov 13, 2020	SELL	$16.2 - $25.7 $1.17 Million - $1.85 Million	-72,000 Closed	0 $0
Q2 2020 Aug 10, 2020	BUY	$5.24 - $23.4 $377,280 - $1.68 Million	72,000 New	72,000 $34,000

126

116M

233K

457K

Ticker MRSN
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 97,169,296
Market Cap $57.3M
Description
Mersana Therapeutics, Inc., a clinical stage biopharmaceutical company, develops antibody drug conjugates (ADC) for cancer patients with unmet need. It develops XMT-1592, a Dolasynthen ADC targeting NaPi2b-expressing tumor cells, which is in phase I clinical trial for the treatment of ovarian cancer and NSCLC adenocarcinoma. The company also dev...

Get notified when there are updates to the investment portfolio of Hap Trading, LLC, based on Form 13F filings with the SEC.

Stay updated on Hap Trading, LLC with notifications on news.